Overview & Mechanism

CJC-1295 is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) designed to stimulate the physiological release of growth hormone through activation of GHRH receptors in the anterior pituitary. By enhancing endogenous growth hormone secretion and increasing circulating IGF-1 levels, CJC-1295 has become a widely investigated peptide in research involving muscle physiology, recovery, metabolic health, and healthy aging.

Key Research Focus Areas:

Growth Hormone Stimulation: Extensively investigated for promoting sustained endogenous growth hormone secretion through selective GHRH receptor activation.

IGF-1 Regulation: Studied for its ability to increase circulating insulin-like growth factor-1 (IGF-1), supporting anabolic and regenerative research models.

Body Composition Research: Evaluated for its potential role in lean muscle preservation, fat metabolism, and overall metabolic efficiency.

Recovery & Healthy Aging: Explored for applications involving tissue regeneration, recovery physiology, sleep quality, and age-related decline in growth hormone production.

Technical Profile & Validation

This lyophilized powder is manufactured to an exceptional research standard exceeding 99% purity. CJC-1295 demonstrates outstanding molecular stability and batch-to-batch consistency, making it suitable for laboratory investigations focused on endocrine physiology, growth hormone regulation, and regenerative biology.

Selected Scientific References

• Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
https://pubmed.ncbi.nlm.nih.gov/16352683/

• Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
https://pubmed.ncbi.nlm.nih.gov/17018654/

Technical Specifications

⚠️ Important Reconstitution Notice Before initiation of the reconstitution protocol, ensure that both the lyophilized peptide vial and the bacteriostatic mixing water have stabilized at room temperature (20°C - 22°C). This step supports proper molecular dissolution and prevents potential destabilization of the micropeptide chain. Note: Bacteriostatic water is distributed separately.

Legal Disclaimer

All compounds and products featured on this platform are synthesized and distributed strictly for laboratory research, in vitro evaluation, and academic studies. These substances are under no circumstances intended, approved, or cleared for human or animal consumption, nor should they be classified as medical products, therapies, drugs, or food supplements.

By executing a purchase, the buyer explicitly assumes all associated biochemical risks and guarantees handling by qualified personnel within a controlled environment. The manufacturer, distributor, and seller maintain a policy of zero liability for any misuse, unauthorized administration, or unverified secondary outcomes. Finalizing your order constitutes full compliance with our academic research terms and conditions.